ArticleBiochemical pharmacology2021

Osimertinib-resistant NSCLC cells activate ERBB2 and YAP/TAZ and are killed by neratinib.

Paul Dent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.